UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Neuropsychopharmacology (New York, N.Y.), 2015-01, Vol.40 (2), p.259-267

2015

Volltextzugriff (PDF)

HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition

Schizophrenia research, 2019-11, Vol.213, p.72-79

2019

Volltextzugriff (PDF)

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders

JAMA psychiatry (Chicago, Ill.), 2017-04, Vol.74 (4), p.399

2017

Volltextzugriff (PDF)

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

American Journal of Psychiatry, 2018-12, Vol.175 (12), p.1205-1215

2018

Volltextzugriff (PDF)

Resting-state connectivity biomarkers define neurophysiological subtypes of depression

Nature medicine, 2017-01, Vol.23 (1), p.28-38

2017

Volltextzugriff (PDF)

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Molecular psychiatry, 2020-07, Vol.25 (7), p.1592-1603

2020

Volltextzugriff (PDF)

Neurobiological Signatures of Anxiety and Depression in Resting-State Functional Magnetic Resonance Imaging

Biological psychiatry (1969), 2015-02, Vol.77 (4), p.385-393

2015

Volltextzugriff (PDF)

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism

Molecular psychiatry, 2019-12, Vol.24 (12), p.1779-1786

2019

Volltextzugriff (PDF)

Social phobia and depression: Prevalence and comorbidity

Journal of psychosomatic research, 2010-03, Vol.68 (3), p.235-243

2010

Volltextzugriff (PDF)

Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control

The Journal of neuroscience, 2007-02, Vol.27 (9), p.2349-2356

2007

Volltextzugriff (PDF)

Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus

Biological psychiatry (1969), 2007-09, Vol.62 (5), p.429-437

2007

Volltextzugriff (PDF)

Circadian patterns of gene expression in the human brain and disruption in major depressive disorder

Proceedings of the National Academy of Sciences - PNAS, 2013-06, Vol.110 (24), p.9950-9955

2013

Volltextzugriff (PDF)

Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis

PloS one, 2018-07, Vol.13 (7), p.e0200003-e0200003

2018

Volltextzugriff (PDF)

Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?

The American journal of psychiatry, 2022-07, Vol.179 (7), p.448-450

Schatzberg, Alan F.

2022

Volltextzugriff (PDF)

Scientific Issues Relevant to Improving the Diagnosis, Risk Assessment, and Treatment of Major Depression

The American journal of psychiatry, 2019-05, Vol.176 (5), p.342-347

Schatzberg, Alan F

2019

Volltextzugriff (PDF)

Mechanisms of Action of Ketamine and Esketamine

The American journal of psychiatry, 2021-12, Vol.178 (12), p.1130-1130

Schatzberg, Alan F

2021

Volltextzugriff (PDF)

Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

Neuropsychopharmacology (New York, N.Y.), 2006-09, Vol.31 (9), p.1841-1853

2006

Volltextzugriff (PDF)

A Word to the Wise About Intranasal Esketamine

The American journal of psychiatry, 2019-06, Vol.176 (6), p.422-424

Schatzberg, Alan F

2019

Volltextzugriff (PDF)

WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN?

Depression and anxiety, 2016-08, Vol.33 (8), p.685-688

2016

Volltextzugriff (PDF)

An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression

The American journal of psychiatry, 2022-12, Vol.179 (12), p.890-891

Schatzberg, Alan F.

2022

Volltextzugriff (PDF)

Post-mortem molecular profiling of three psychiatric disorders

Genome medicine, 2017-07, Vol.9 (1), p.72-72, Article 72

2017

Volltextzugriff (PDF)

Common Abnormalities and Disorder-Specific Compensation During Implicit Regulation of Emotional Processing in Generalized Anxiety and Major Depressive Disorders

The American journal of psychiatry, 2011-09, Vol.168 (9), p.968-978

2011

Volltextzugriff (PDF)

A Word to the Wise About Ketamine

The American journal of psychiatry, 2014-03, Vol.171 (3), p.262-264

Schatzberg, Alan F.

2014

Volltextzugriff (PDF)

Splice-Break: exploiting an RNA-seq splice junction algorithm to discover mitochondrial DNA deletion breakpoints and analyses of psychiatric disorders

Nucleic acids research, 2019-06, Vol.47 (10), p.e59-e59

2019

Volltextzugriff (PDF)

Development of New Psychopharmacological Agents for Depression and Anxiety

The Psychiatric clinics of North America, 2015-09, Vol.38 (3), p.379-393

Schatzberg, Alan F

2015

Volltextzugriff (PDF)

1 – 25 von 461

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(392)
Mit Volltextzugriff
(341)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(298)
Life Sciences & Biomedicine
(286)
Humans
(264)
Psychiatry
(245)
Male
(176)
Female
(169)
Adult
(138)
Biological And Medical Sciences
(132)
Psychology. Psychoanalysis. Psychiatry
(114)
Medical Sciences
(112)
Middle Aged
(109)
Neurosciences & Neurology
(87)
Neurosciences
(80)
Psychopathology. Psychiatry
(80)
Depression
(78)
Aged
(67)
Treatment Outcome
(65)
Mental Depression
(64)
Antidepressive Agents - Therapeutic Use
(60)
Adult And Adolescent Clinical Studies
(58)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

HPA axis in psychotic major depression and schizophrenia spectrum disorders: Cortisol, clinical symptomatology, and cognition

A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders

Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism

Resting-state connectivity biomarkers define neurophysiological subtypes of depression

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Neurobiological Signatures of Anxiety and Depression in Resting-State Functional Magnetic Resonance Imaging

Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism

Social phobia and depression: Prevalence and comorbidity

Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control

Resting-State Functional Connectivity in Major Depression: Abnormally Increased Contributions from Subgenual Cingulate Cortex and Thalamus

Circadian patterns of gene expression in the human brain and disruption in major depressive disorder

Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis

Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?

Scientific Issues Relevant to Improving the Diagnosis, Risk Assessment, and Treatment of Major Depression

Mechanisms of Action of Ketamine and Esketamine

Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

A Word to the Wise About Intranasal Esketamine

WHITHER KETAMINE AS AN ANTIDEPRESSANT: PANACEA OR TOXIN?

An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression

Post-mortem molecular profiling of three psychiatric disorders

Common Abnormalities and Disorder-Specific Compensation During Implicit Regulation of Emotional Processing in Generalized Anxiety and Major Depressive Disorders

A Word to the Wise About Ketamine

Splice-Break: exploiting an RNA-seq splice junction algorithm to discover mitochondrial DNA deletion breakpoints and analyses of psychiatric disorders

Development of New Psychopharmacological Agents for Depression and Anxiety

Suchergebnisse filtern